Google
×
Conclusion: Patients with metastatic RCC, less than three metastatic locations and a Karnofsky score >70% can be considered for HSCT. Posttransplant DLI and ...
We evaluated the experience of allogeneic haematopoietic stem cell transplantation (HSCT) for renal cell carcinoma (RCC) in 124 patients from 21 European ...
We evaluated the experience of allogeneic HSCT for renal cell carcinoma (RCC) in Europe. Methods and Patients: We report the data on 124 patients with clear ...
Missing: haematopoietic | Show results with:haematopoietic
Nov 15, 2006 · Another immunotherapy approach being studied for the treatment of metastatic RCC is allogeneic hematopoietic stem cell transplantation as a ...
A study by Childs et al. [5] showed that patients with a lower tumor burden had a better outcome. This was also seen in the experience of the European data ...
Allogeneic hematopoietic SCT (HSCT) has been shown to be an effective treatment option for advanced renal cell cancer (RCC). However, tumor resistance/relapse ...
Allogeneic hematopoietic stem cell transplantation from a compatible donor has been utilized as adoptive immunotherapy in metastatic, cytokine‐refractory renal ...
Missing: Europe | Show results with:Europe
People also ask
Allogeneic stem-cell transplantation remains a research-based approach for patients who have not responded to conventional treatments for metastatic RCC. GVHD ...
Nov 1, 2004 · The management of metastatic renal cell carcinoma (mRCC) remains a therapeutic challenge; less than 10% of patients survive for longer than 5 years.
Missing: haematopoietic | Show results with:haematopoietic
Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe. L. Barkholt, M. Bregni, M. Remberger, D. Blaise, J. Peccatori ...